Statistical Data on Drugs in Puerto Rico
Puerto Rico faces significant challenges with substance abuse and addiction, affecting approximately 70,000 individuals with an estimated $3 million spent daily on illicit drugs. The total annual cost to Puerto Rican and U.S. governments exceeds $600 million. This compilation presents statistics on drug abuse patterns, treatment services, overdose trends, and the evolving opioid crisis in Puerto Rico, drawing from government reports, treatment admission data, and recent epidemiological studies spanning from 1998 to 2023.
Overdose Fatalities (2020-2022)
Overall Fatality Rates
| Year | Total Overdose Cases | Deaths | Fatality Rate |
| 2020 | 125 | 8 | 6.4% |
| 2021 | 473 | 23 | 4.9% |
| 2022 | 713 | 33 | 4.6% |
Fatality Cases by Naloxone Administration
| Category | 2020 | 2021 | 2022 |
| Fatalities WITHOUT naloxone | 1 (12.5%) | 16 (69.6%) | 15 (45.5%) |
| Fatalities WITH naloxone | 7 (87.5%) | 7 (30.4%) | 18 (54.5%) |
Substances in Fatal Overdoses
| Substance | 2020 | 2021 | 2022 |
| Fentanyl and heroin combined | 4 (50.0%) | 11 (47.8%) | 12 (36.7%) |
| Heroin alone | 3 (37.5%) | 6 (26.0%) | 7 (21.2%) |
| Fentanyl alone | 1 (12.5%) | 1 (4.3%) | 3 (9.1%) |
Total overdose deaths reported:
- 2021: 633 deaths
- 2022: 590 deaths linked to fentanyl (rising to 635 total deaths in 2023)
Fatality rates improved from 6.4% to 4.6%, despite increasing case volumes. However, the pattern of naloxone use in fatal cases changed dramatically: in 2021, 69.6% of deaths occurred without naloxone administration, suggesting delayed emergency response. The persistent fatalities even with naloxone administration (54.5% in 2022) indicates either delayed treatment, inadequate dosing, or extremely potent drug combinations.
Stateside Puerto Rican Drug Mortality (2009-2018; per 100,000)
Age-Adjusted Drug Overdose Mortality Rates
| Population | 2009 Rate | 2018 Rate | Increase |
| Puerto Rican Women | 6.0 | 12.5 | Doubled |
| Puerto Rican Men | 15.3 | 45.2 | Nearly tripled |
| Overall Puerto Rican-heritage (2018) | 28.7 | – | – |
| Non-Hispanic White (2018) | 26.2 | – | – |
Highest-risk group (2018): Puerto Rican-heritage men ages 45-54: 104.1 per 100,000
Stateside Puerto Rican men experienced an alarming near-tripling of overdose mortality, with middle-aged men (45-54) facing crisis-level rates exceeding 100 per 100,000. By 2018, Puerto Rican-heritage individuals surpassed non-Hispanic Whites in overdose mortality, representing a significant and growing health disparity.
Substances Involved in Opioid Overdose Patterns (2020-2022)
| Substance | 2020 | 2021 | 2022 |
| Fentanyl + Other Substances | 38.7% | 30.2% | 20.76% |
| Unknown Substances | 35.5% | 42.3% | 53.02% |
| Heroin | 21.8% | 20.7% | 17.1% |
| Fentanyl Alone | 4.0% | 4.2% | 7.2% |
| Prescription Opioids | – | 2.5% | 2.0% |
A dramatic shift occurred over three years: unknown substances increased from 35.5% to 53.02%, while fentanyl combinations decreased from 38.7% to 20.76%. Heroin showed declining prevalence each year. The high percentage of unknown substances suggests challenges in rapid toxicology identification and the emergence of novel drug combinations.
Substance Abuse Patterns
Heroin
- Most commonly abused substance among Hispanic Puerto Ricans
- Treatment admissions (2000-2001): 43.5% of Puerto Ricans vs. 13.2% of other Hispanics
- Primary drug of choice: 23% of males, 20% of females
Marijuana
- Treatment admissions: 14.3% of Hispanic Puerto Ricans, 17.7% of other Hispanics
- Puerto Ricans have highest rate of recent marijuana use among Hispanic groups: 5.6%
- Lowest rates: Cubans and South Americans (2.1%)
General Illicit Drug Use
- Puerto Ricans have highest rate of recent illicit drug use among Hispanic populations: 6.9%
- South Americans have lowest rate: 2.1%
Puerto Ricans demonstrate significantly higher rates of heroin abuse compared to other Hispanic groups (more than 3× higher), representing a distinct public health challenge. Puerto Ricans also lead all Hispanic groups in both general illicit drug use and marijuana use.
Substance Use Disorders Prevalence (2016 Study)
Overall Population Statistics
- 11.5% of adults (18-64) met criteria for any substance use disorder in the past 12 months
- of adults (57,301 people) needed substance use services due to dependence
- 8.2% had a history of illicit drug use
- 1.2% qualified for lifetime diagnosis of drug abuse, dependence, or both
Specific Disorders (12-Month Prevalence)
- Alcohol abuse disorder: 5.2%
- Alcohol dependence: 1.5%
- Nicotine dependence: 5.1%
Gender Differences
- Male drug users meeting criteria for abuse/dependence: 18.4%
- Female drug users meeting criteria for abuse/dependence: 7.7%
- Women significantly less likely than men to be diagnosed with substance use disorders
Age Distribution
26-45 age group showed highest prevalence:
- Any substance use disorder: 5.1%
- Nicotine dependence: 2.4%
- Any alcohol use disorder: 2.4%
- Any drug use disorder: 1.5%
Regional Patterns
San Juan health region (highest rates):
- Alcohol use disorder: 8.9%
- Alcohol abuse: 8.2%
- Alcohol dependence: 2.5%
Over 1 in 10 adults in Puerto Rico struggled with substance use disorders, with men at more than twice the risk of women. The concentration of alcohol disorders in San Juan suggests urban-specific risk factors or better detection/reporting in metropolitan areas.
Treatment Facilities and Infrastructure
Facility Distribution (1998)
- State-run treatment facilities: 2
- Not-for-profit facilities: 3
- Not-for-profit faith-based programs: 35
- For-profit treatment facilities: 6
2013 Treatment Facility Survey (N-SSATS)
- Total facilities surveyed: 161 (87% response rate)
- Total clients in treatment (March 29, 2013): 15,169
- Clients under age 18: 680 (4.5%)
| Facility Type | Number | Percentage | Clients | Client Percentage |
| Private non-profit | 109 | 67.7% | 2,681 | 18.2% |
| State government | 27 | 16.8% | 10,451 | 70.8% |
| Private for-profit | 23 | 14.3% | 1,636 | 11.1% |
| Local/county/community government | 1 | 0.6% | ^ | ^ |
| Federal government | 1 | 0.6% | ^ | ^ |
State government facilities, though representing only 16.8% of facilities, served the overwhelming majority of clients, indicating the critical role of public sector treatment programs. Private non-profit facilities were most numerous but served a smaller client population per facility.
Facility Capacity and Utilization (2013)
| Facility Type | Number | Clients | Designated Beds | Utilization Rate | Avg. Beds/Facility |
| Residential | 94 | 2,280 | 3,027 | 75.3% | 32 |
| Hospital Inpatient | 7 | 446 | 178 | 250.6% | 25 |
Hospital inpatient facilities operated at 250.6% capacity, indicating severe overcrowding and urgent need for expanded inpatient treatment infrastructure. Residential facilities maintained healthier utilization at 75.3%.
Treatment Features
Substance-Specific Treatment Data (March 29, 2013)
| Problem Treated | Facilities | Facilities (%) | Clients | Clients (%) | Per 100,000 (18+) |
| Drug abuse only | 107 | 70.4% | 7,982 | 61.0% | 270 |
| Both alcohol and drug | 124 | 81.6% | 4,085 | 31.2% | 137 |
| Alcohol abuse only | 86 | 56.6% | 1,025 | 7.8% | 36 |
Drug abuse (either alone or combined with alcohol) accounts for 92.2% of all treatment clients, highlighting the predominance of illicit drug problems over alcohol-only issues in Puerto Rico.
Types of Care Provided (March 29, 2013)
| Type of Care | Facilities | % of Facilities | Clients | % of Clients | Clients Under 18 |
| Outpatient (any) | 64 | 39.8% | 12,119 | 79.9% | 457 (67.2%) |
| – Regular outpatient | 51 | 31.7% | 2,926 | 19.3% | – |
| – Intensive outpatient | 27 | 16.8% | 1,239 | 8.2% | – |
| – Methadone/buprenorphine maintenance | 17 | 10.6% | 7,508 | 49.5% | – |
| – Day treatment | 24 | 14.9% | 345 | 2.3% | – |
| Residential (non-hospital) | 106 | 65.8% | 2,511 | 16.6% | 212 (31.2%) |
| – Long term (30+ days) | 105 | 65.2% | 2,230 | 14.7% | – |
| – Short term (<30 days) | 22 | 13.7% | 85 | 0.6% | – |
| Hospital Inpatient | 15 | 9.3% | 539 | 3.6% | 11 (1.6%) |
Nearly half (49.5%) of all treatment clients received medication-assisted treatment (MAT) with methadone or buprenorphine, demonstrating strong integration of evidence-based opioid treatment. However, outpatient services dominated, serving 79.9% of clients despite representing only 39.8% of facilities.
Opioid Treatment Programs (2013)
| Category | Number | Percentage |
| Facilities with OTPs | 8 | 0.6% |
| Clients receiving methadone | 8,340 | 95.3% |
| Clients receiving buprenorphine (non-OTP facilities) | 380 | 4.3% |
| Clients receiving Vivitrol® (non-OTP facilities) | 33 | 0.4% |
| Total opioid treatment clients | 8,753 | 100% |
Clients per 100,000 Population:
- Methadone: 231
- Buprenorphine: 11
- Vivitrol®: 1
Methadone dominated medication-assisted treatment, with 95.3% of opioid treatment clients receiving it. The concentration in only 8 OTP facilities suggests limited geographic access to specialized opioid treatment services.
Prior Treatment History
- 70.5% of Puerto Rican admissions had at least one prior treatment episode
- Puerto Ricans of Puerto Rican descent were 15.1% more likely to need specialty treatment than Hispanics of other descent
- 2007 admissions: 70,700 Puerto Ricans
The high rate of prior treatment (70.5%) indicates significant relapse challenges and suggests the need for enhanced aftercare services and long-term recovery support.
Treatment Gaps and Unmet Needs
Adults Not Receiving Treatment
| Disorder | Percentage with Unmet Need |
| Alcohol dependence | 69.8% |
| Drug dependence | 56.4% |
| Any substance dependence | 67.4% |
Gender-specific gap: males with substance dependence not receiving treatment: 48.7% (largest percentage)
Barriers to Treatment (Among Those with Perceived Unmet Need)
- Believed problem would get better on its own: 78.9%
- Wanted to handle problems independently: 72.4%
- Believed treatment would not work: 71.7%
Nearly 7 in 10 adults needing substance use services did not receive treatment, with attitudinal barriers dominating over structural ones. The prevalence of self-reliance beliefs (72.4%) and treatment skepticism (71.7%) suggests the need for public education campaigns addressing treatment effectiveness and reducing stigma.
Treatment with Naloxone
Naloxone Administration Usage Patterns (2020-2022)
| Parameter | 2020 | 2021 | 2022 |
| Patients receiving naloxone | 94.4% | 94.5% | 96.9% |
| Patients NOT receiving naloxone | 5.6% | 5.5% | 3.1% |
| Intranasal administration | 92.7% | 91.8% | 76.0% |
| Intramuscular/IV administration | 0.8% | 1.9% | 20.6% |
Naloxone administration rates improved each year, reaching 96.9% in 2022. A significant shift occurred in administration routes: intramuscular/IV administration increased dramatically from 0.8% to 20.6%, possibly reflecting more severe overdoses requiring alternative routes or protocol changes by emergency responders.
Naloxone Administrators
| Administrator Type | 2020 | 2021 | 2022 |
| Medical Emergency Personnel | 42 (33.9%) | 201 (42.5%) | 455 (63.8%) |
| Friends | 25 (20.2%) | 101 (21.4%) | 143 (20.1%) |
| Citizens (Civil) | 26 (21.0%) | 110 (23.3%) | 38 (5.3%) |
| Self-administered | 7 (5.6%) | 8 (1.7%) | 8 (1.1%) |
| Family Members | 2 (1.6%) | 4 (0.8%) | 2 (0.3%) |
| Police | 4 (3.2%) | 0 | 1 (0.1%) |
Trained Administrators:
- 2020: 90.3%
- 2021: 82.9%
- 2022: 40.8%
Medical emergency personnel increasingly dominated naloxone administration, while trained administrator percentage dropped precipitously from 90.3% to 40.8%. This suggests either expanded layperson naloxone access or reporting changes. The minimal involvement of family members (consistently <2%) indicates a potential gap in harm reduction education for close contacts of drug users.
Naloxone Doses Required per Patient
| Doses | 2020 | 2021 | 2022 |
| 0 doses | 7 (5.9%) | 19 (4.5%) | 12 (1.7%) |
| 1 dose | 33 (27.7%) | 139 (33.1%) | 418 (60.2%) |
| 2 doses | 74 (62.2%) | 254 (60.5%) | 237 (34.1%) |
| 3 doses | 1 (0.8%) | 3 (0.7%) | 18 (2.6%) |
| 4 doses | 3 (2.5%) | 4 (1.0%) | 6 (0.9%) |
| 5 doses | 0 | 0 | 2 (0.2%) |
| 8 doses | 1 (0.8%) | 1 (0.2%) | 0 |
A significant positive trend emerged: the percentage of patients requiring only 1 dose more than doubled from 27.7% in 2020 to 60.2% in 2022, while those requiring 2 doses fell from 62.2% to 34.1%. This suggests either earlier intervention, changes in opioid potency, or improved naloxone administration protocols.
HIV and Hepatitis C Burden
- People living with diagnosed HIV (2021): 15,801
- Syringe Exchange Programs (2024): 2
- Facilities providing MAT (2023): 32
- 30-day supply of opioids per Part D enrollee (2015): 0.8 (compared to U.S. average of 2.1)
The presence of only 2 syringe exchange programs for nearly 16,000 people living with HIV represents a critical gap in harm reduction infrastructure. However, opioid prescribing rates were substantially lower than the U.S. mainland average, suggesting the island’s opioid crisis is driven primarily by illicit drug use rather than prescription medications.
Crime and Law Enforcement
Drug-Related Crime Statistics
- 63% of 744 murders in 2001 were drug-related
- 17.9% of federal drug sentences were heroin-related (Department of Justice)
Law Enforcement Actions
- September 2010: 89 law enforcement officers + 44 others arrested on cocaine trafficking charges (2-year investigation)
- May 2010: 39 people arrested for trafficking in heroin, crack, cocaine, marijuana, and prescription opioids
Drug Seizures (2008)
| Drug Type | Kilograms Seized |
| Marijuana | 24,702.72 |
| Powder Cocaine | 17,113.35 |
| Heroin | 78.98 |
| Crack Cocaine | 4.52 |
Federal Sentencing
- 687 sentenced drug trafficking offenders in Puerto Rico
The prevalence of drug-related murders (63% of all homicides) demonstrates the violent nature of Puerto Rico’s drug trade. The corruption of law enforcement personnel (89 officers arrested) highlights systemic challenges in combating drug trafficking.
Federal Funding (CDC Overdose Prevention Funding (FY23))
Total appropriated: $1,005,610
Federal overdose prevention funding appears modest relative to the scale of the crisis, particularly given 633 annual overdose deaths and treatment needs of over 57,000 adults with substance dependence.
Final Words
Puerto Rico faces a severe substance abuse crisis affecting approximately 70,000 individuals, with annual costs exceeding $600 million and fentanyl deaths rising from 590 to 635 between 2022-2023. Despite improvements in naloxone administration rates, two-thirds of adults with substance dependence receive no treatment due primarily to attitudinal barriers rather than access issues. Hospital inpatient facilities operate at 250% capacity, and the shift toward unknown substances (53% of overdoses in 2022) indicates an evolving and increasingly dangerous drug supply. Addressing this crisis requires expanded treatment infrastructure, enhanced harm reduction services, and public education campaigns to overcome treatment skepticism and reduce stigma.
Statistical Data on Alcohol in Puerto Rico
Alcohol use disorders represent a significant public health concern in Puerto Rico, with varying prevalence rates across gender, family structure, and geographic location. This compilation presents data on alcohol consumption patterns, mortality rates, prevalence of alcohol use disorders, and economic indicators related to alcohol sales, drawing from epidemiological studies, mortality records, and market research spanning from 1961 to 2025.
Alcohol-Related Mortality Rates (per 100,000 Population)
| Cause of Death | Year | Puerto Rico | U.S. Total |
| Chronic liver disease and cirrhosis | 2004 | 2.6 | – |
| Alcohol-induced causes (all) | 2012 | 5.6 | 8.0 |
Puerto Rico’s alcohol-induced mortality rate (5.6 per 100,000) was lower than the U.S. average (8.0 per 100,000) in 2012. The broader alcohol-induced causes category includes dependent and non-dependent use of alcohol plus accidental poisoning by alcohol, providing a more comprehensive view than liver disease alone.
Alcohol Per Capita Consumption Patterns (Population 15+ Years)
Average Consumption (Liters of Pure Ethanol)
| Type of Consumption | 2003-2005 (Avg.) | 2008-2010 (Avg.) | Change |
| Recorded consumption | 5.4 | 4.9 | ➙ Decrease |
| Unrecorded consumption | 0.3 | 0.5 | ➚ Increase |
| Total consumption | 5.7 | 5.4 | ➙ Decrease |
By Gender
- Males: 7.2 liters
- Females: 3.4 liters
Regional Comparison
- WHO Region of the Americas (2003-2005): 9.2 liters
- WHO Region of the Americas (2008-2010): 8.4 liters
Puerto Rico’s total per capita alcohol consumption was significantly lower than the WHO Americas regional average in 2008-2010. Males consumed more than twice the amount of alcohol compared to females. While recorded consumption decreased slightly, unrecorded consumption increased by 67%, suggesting a shift toward informal or unregulated alcohol sources.
Stateside Puerto Rican Drinking Patterns (Binge Drinking Rates)
- Nearly half of drinking adults of Puerto Rican ancestry binge drink weekly
- 51.1% of Puerto Rican women in the U.S. who drink participate in binge drinking (highest among any Hispanic group by far)
Stateside Puerto Rican women show dramatically elevated binge drinking rates compared to island rates, representing the highest rate among all Hispanic groups in the United States. This suggests significant acculturation effects or selection bias in migration patterns, and highlights a critical health disparity among stateside Puerto Rican communities.
Prevalence of Alcohol Use Disorders
Lifetime DSM-5 AUD Prevalence (San Juan)
| Population | Overall Lifetime AUD | Mild AUD |
| Men | 38% | 18% |
| Women | 16% | 9% |
Most Common AUD Criteria (Independent of Gender and Severity)
Drinking larger quantities and for longer than planned:
- Men: 80-97% endorsement
- Women: 78-91% endorsement
Hazardous use:
- Men: 56-91% endorsement
- Women: 42-74% endorsement
AUD prevalence in San Juan was notably high, with more than one-third of men and nearly one in six women meeting lifetime criteria. Mild AUD was most prevalent for both genders. The near-universal endorsement of loss of control over drinking suggests this is the most common pathway to alcohol problems in Puerto Rico, followed by hazardous use patterns.
Binge Drinking and AUD by Family Cohesion (2014)
Men (N=665)
| Family Cohesion Level | Sample Size | Binge Drinking (Past 12 Months) | DSM-5 AUD (Past 12 Months) |
| Low | 154 | 37% | 20% |
| Medium | 211 | 23% | 19% |
| High | 300 | 21% | 7% |
| Total | 665 | 26% | 14% |
Women (N=788)
| Family Cohesion Level | Sample Size | Binge Drinking (Past 12 Months) | DSM-5 AUD (Past 12 Months) |
| Low | 182 | 22% | 13% |
| Medium | 252 | 15% | 6% |
| High | 354 | 15% | 4% |
| Total | 788 | 17% | 7% |
Family cohesion showed a strong protective effect against alcohol use disorders, particularly for men. Men with low family cohesion had nearly three times the AUD rate compared to those with high cohesion (20% vs. 7%). Women showed similar but less pronounced patterns. Overall, men had twice the rate of both binge drinking (26% vs. 17%) and AUD (14% vs. 7%) compared to women.
Alcohol Market Revenue (2025)
Revenue by Sales Channel
- At-home consumption (Supermarkets and convenience stores): US$934.8 million
- Out-of-home consumption (Restaurants and bars): US$788.8 million
- Total combined (All channels): US$1.7 billion
- At-home revenue expected annual growth: 2.05%
Alcohol market in Puerto Rico generates $1.7 billion in annual revenue, with at-home consumption (54.9%) slightly exceeding out-of-home consumption (45.1%). The modest projected growth rate of 2.05% suggests a mature, stable market. The high revenue figures demonstrate the significant economic scale of alcohol sales despite relatively moderate per capita consumption rates.
Final Words
Puerto Rico shows moderate alcohol consumption (5.4 liters per capita) below regional averages, yet AUD prevalence remains high at 38% of men and 16% of women in San Juan. Family cohesion provides strong protection, reducing AUD rates threefold, while men consistently show double the risk compared to women. The most alarming disparity is among stateside Puerto Rican women, whose binge drinking rate (51.1%) triples island rates and is highest among all U.S. Hispanic groups, highlighting critical migration-related health disparities requiring targeted intervention.
Conclusion
In general, Puerto Rico confronts a dual substance abuse crisis: approximately 70,000 individuals struggle with drug addiction (costing $600+ million annually) while AUD affects 38% of men and 16% of women, despite moderate alcohol consumption below regional averages. Critical infrastructure gaps persist with hospital facilities operating at 250% capacity and two-thirds of those needing treatment not receiving it, driven primarily by attitudinal barriers and treatment skepticism. The crisis is evolving dangerously with fentanyl deaths rising to 635 in 2023 and unknown substances now comprising 53% of overdoses, while family cohesion emerges as a powerful protective factor reducing AUD rates threefold. Stateside Puerto Ricans face the most severe disparities—men aged 45-54 with overdose mortality exceeding 100 per 100,000 and women showing the highest binge drinking rate (51.1%) among all U.S. Hispanic groups—underscoring urgent needs for expanded treatment infrastructure, enhanced harm reduction services, and culturally-targeted interventions addressing both island and diaspora populations.
Sources:
- Puerto Rico Drug Abuse Statistics | Recovery Connection
- Puerto Rico Drug Addiction
- Substance Abuse Statistics for Hispanic American
- Opioid Use and Overdose Patterns in Puerto Rico in 2020-2022: A Retrospective Descriptive Study
- Drug abuse and illicit drug use in Puerto Rico. | AJPH | Vol. 83 Issue 2
- Puerto Rico Funding Priorities
- 2013 State Profile – Puerto Rico National Survey of Substance Abuse Treatment Services (N-SSATS)
- Need Assessment Study of Mental Health and Substance Use Disorders and Service Utilization among Adult Population of Puerto Rico
- Drug Threat Overview – Puerto Rico/U.S. Virgin Islands High Intensity Drug Trafficking Area Drug Market Analysis 2009
- Drug overdose mortality among stateside Puerto Ricans: Evidence of a health disparity – ScienceDirect
- Puerto Rico police investigate 8 deaths and about two dozen suspected fentanyl overdoses in one town
- Puerto Rico Opioid Epidemic
- Drug Trafficking by the Numbers
- Family Cohesion and Pride: Drinking and Alcohol Use Disorders in Puerto Rico – PMC
- Alcoholic Drinks – Puerto Rico | Statista Market Forecast
- The Prevalence of Alcohol Use Disorders in Puerto Rico is High | Newswise
- Puerto Rico
- Latino Americans And Alcohol